Identifying new protein interactions to improve disease treatment
Official title: Exploring Understudied Proteins to Predict Novel Pathways and Associations to Disease
Funded at Stanford University · NIH-10995987 · Data updated 2026-11-12
This study is looking at some lesser-known proteins to find new ways to develop better treatments for diseases, which could help patients get more effective options for their care.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2026 |
| Funding year | 2024 |
| Award (this year) | $48,974 |
| NIH project number | 1F31LM014646-01 |
| Project ID | NIH-10995987 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with diseases that have limited treatment options due to poorly understood biological pathways.
✕Less likely to help
Patients with well-characterized diseases that already have effective treatments may not benefit from this research.
What this research studies
This research investigates the role of understudied proteins in disease pathways to enhance drug discovery. By utilizing high-throughput datasets, the project aims to uncover novel protein interactions that have been overlooked in traditional studies. The approach combines computational algorithms with biological data to predict new pathways that could lead to effective treatments for various diseases. Patients may benefit from this research as it seeks to identify new therapeutic targets that could improve treatment options.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drug targets, potentially resulting in effective treatments for currently untreatable diseases.
How similar studies have gone: Previous research has shown promise in utilizing high-throughput data to uncover novel biological pathways, suggesting that this approach could yield significant advancements.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Nayar, Gowri — Stanford University
- Study coordinator: Nayar, Gowri
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.